Your browser doesn't support javascript.
loading
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Kilmartin, Darren; O'Loughlin, Mark; Andreu, Xavier; Bagó-Horváth, Zsuzsanna; Bianchi, Simonetta; Chmielik, Ewa; Cserni, Gábor; Figueiredo, Paulo; Floris, Giuseppe; Foschini, Maria Pia; Kovács, Anikó; Heikkilä, Päivi; Kulka, Janina; Laenkholm, Anne-Vibeke; Liepniece-Karele, Inta; Marchiò, Caterina; Provenzano, Elena; Regitnig, Peter; Reiner, Angelika; Ryska, Ales; Sapino, Anna; Specht Stovgaard, Elisabeth; Quinn, Cecily; Zolota, Vasiliki; Webber, Mark; Roshan, Davood; Glynn, Sharon A; Callagy, Grace.
Afiliação
  • Kilmartin D; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland.
  • O'Loughlin M; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland.
  • Andreu X; UDIAT-Centre Diagnòstic, Pathology Department, Institut Universitari Parc Taulí-UAB, Parc Taulí, 1, 08205 Sabadell, Spain.
  • Bagó-Horváth Z; Department of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Bianchi S; Division of Pathological Anatomy, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
  • Chmielik E; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
  • Cserni G; Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
  • Figueiredo P; Laboratório de Anatomia Patológica, Instituto Politécnico de Coimbra, 3000-075 Coimbra, Portugal.
  • Floris G; Laboratory of Translational Cell and Tissue Research, Department of Imaging and Pathology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Foschini MP; Unit of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bellaria Hospital, 40139 Bologna, Italy.
  • Kovács A; Department of Clinical Pathology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
  • Heikkilä P; Department of Pathology, Helsinki University Central Hospital, 00029 Helsinki, Finland.
  • Kulka J; 2nd Department of Pathology, Semmelweis University Budapest, Ülloi út 93, 1091 Budapest, Hungary.
  • Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, 4000 Roskilde, Denmark.
  • Liepniece-Karele I; Department of Pathology, Riga Stradins University, LV-1007 Riga, Latvia.
  • Marchiò C; Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.
  • Provenzano E; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Regitnig P; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge CB2 0QQ, UK.
  • Reiner A; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
  • Ryska A; Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
  • Sapino A; Department of Pathology, Klinikum Donaustadt, 1090 Vienna, Austria.
  • Specht Stovgaard E; The Fingerland Department of Pathology, Charles University Medical Faculty and University Hospital, 50003 Hradec Kralove, Czech Republic.
  • Quinn C; Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, 10060 Candiolo, Italy.
  • Zolota V; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Webber M; Pathology Department, Herlev University Hospital, DK-2730 Herlev, Denmark.
  • Roshan D; Irish National Breast Screening Programme, BreastCheck, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.
  • Glynn SA; School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
  • Callagy G; Department of Pathology, School of Medicine, University of Patras, 26504 Rion, Greece.
Cancers (Basel) ; 13(17)2021 Aug 31.
Article em En | MEDLINE | ID: mdl-34503219
ABSTRACT
Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539-0.735, p < 0.001) but was poor to fair using binary cutpoints. sTILs heterogeneity was the main contributor to disagreement. When pathologists scored the same FOV from each case, inter-observer agreement was excellent for absolute sTILs (ICC 0.798, 95% CI 0.727-0.864, p < 0.001) and good for the 20% (ICC 0.657, 95% CI 0.561-0.756, p < 0.001) and 40% (ICC 0.644, 95% CI 0.546-0.745, p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda